Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Bionano Genomics, Inc. (BNGO)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-KS-1/A
Operating activities:         
    Adjustments to reconcile net loss to net cash used by operating activities:         
        Depreciation and amortization expense  9.63.41.51.11.31.5 
        Non-cash lease expense  0.50.7     
        Net realized loss (gain) on investments  0.1      
        Stock-based compensation  22.49.71.61.31.20.4 
        Change in fair value of contingent consideration  0.30.1     
        Cost of leased equipment sold to customer  0.20.6     
        Changes in operating assets and liabilities:         
            Accounts receivable  -2.9-0.52.1-2.4-0.9-1.8 
            Inventory  -23.7-15.9-4.2-3.6-0.4-0.3 
            Prepaid expenses and other current assets  -3.2-1.3-1.0-0.20.20.8 
            Other assets  -1.1-0.6     
            Accounts payable  1.96.8-1.81.4-1.01.5 
            Accrued expenses and contract liabilities  0.44.01.5-0.1-0.2-0.1 
                Net cash used in operating activities  -124.8-71.9-38.3-29.5-19.9-20.8 
   
Investing Activities:         
    Purchases of property and equipment  -2.4-0.8     
    Purchase of available for sale securities  -84.2-313.4     
    Sale and maturity of available for sale securities  200.986.5     
    Construction in progress  -0.8-0.6     
    Sale of property and equipment  0.0      
        Net cash provided by investing activities  82.8-278.1-2.5-0.1-0.3-1.0 
   
Financing activities:         
    Proceeds from sale of common stock  23.1342.739.919.619.4  
    Offering expenses on sale of common stock  -0.6-1.7-2.0    
    Proceeds from warrant and option exercises  0.310.028.70.90.0  
        Net cash provided by financing activities  23.0336.161.930.435.817.6 
Effect of exchange rates on cash, cash equivalents and restricted cash  0.0      
   
Reconciliation of cash, cash equivalents and restricted cash reported within the unaudited condensed consolidated balance sheets to the total amounts reported on the unaudited condensed consolidated statements of cash flows         
Cash and cash equivalents         
Restricted cash         
   
Supplemental cash flow disclosures:         
    Cash paid for interest  0.31.91.31.30.70.5 
    Cash paid for operating lease liabilities  1.60.4     
    Supplemental disclosure of non-cash investing and financing activities:         
        Property and equipment included in accounts payable  0.1   0.00.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy